Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-06-27

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for levocetirizine dihydrochloride (Glenmark Pharmaceuticals Inc., USA) under the ANDA process, leading to labeling upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)